LEECC, ANDERSONRC. Toxicologic studies on vancomycin and polyethylene glycol 200. Toxicol Appl Pharmacol1962; 4: 206–14.
2.
ARONOFFGR, SLOANRS, DINWIDDIECB, GLANTMD, FINEBERGNS, LUFTFC. Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother1981; 19: 306–8.
3.
WAISBRENBA, KLEINERMANL, SKEMPS, BRATCHERG.Comparative effectiveness and toxicity of vancomycin, ristocetin and kanamycin. Arch Intern Med1960; 106: 179–93.
4.
KIRBYWM. Vancomycin therapy of staphylococcal infections. Antibiot Chemother1963; 11: 84–96.
5.
WOODLEYDW, HALLWH. Treatment of severe staphyloccal infection with vancomycin. Ann Intern Med1961; 55: 235–49.
6.
APPELGB, NEWHC. The nephrotoxicity of antimicrobial agents. N Engl J Med1977; 296: 722–8.
7.
COOKFV, FARRARWE. Vancomycin revisted. Ann Intern Med1978; 88: 813–8.
8.
EISENBERGES, ROBBINSN, LENCIM.Vancomycin and interstitial nephritis (letter). Ann Intern Med1981; 95: 658.
9.
LINTONAL, CLARKWF, DRIEGERAA, TURNBULLI, LINDSAYRM. Acute interstitial nephritis due to drugs. Ann Intern Med1980; 93: 735–41.
10.
GERACHIJE, HERMANSPE. General review of vancomycin. Mayo Clin Proc1983; 57: 88–91.
11.
FARBERBF, MOELLERINGRC. Retrospective study of toxicity of preparations of vancomycin from 1974–1981. Antimicrob Agents Chemother1983; 23: 138–41.
